Literature DB >> 25180603

Neurotrophin receptor p75(NTR) mediates Huntington's disease-associated synaptic and memory dysfunction.

Verónica Brito, Albert Giralt, Lilian Enriquez-Barreto, Mar Puigdellívol, Nuria Suelves, Alfonsa Zamora-Moratalla, Jesús J Ballesteros, Eduardo D Martín, Nuria Dominguez-Iturza, Miguel Morales, Jordi Alberch, Sílvia Ginés.   

Abstract

Learning and memory deficits are early clinical manifestations of Huntington's disease (HD). These cognitive impairments have been mainly associated with frontostriatal HD pathology; however, compelling evidence provided by several HD murine models suggests that the hippocampus may contribute to synaptic deficits and memory dysfunction in HD. The neurotrophin receptor p75(NTR) negatively regulates spine density, which is associated with learning and memory; therefore, we explored whether disturbed p75(NTR) function in the hippocampus could contribute to synaptic dysfunction and memory deficits in HD. Here, we determined that levels of p75(NTR) are markedly increased in the hippocampus of 2 distinct mouse models of HD and in HD patients. Normalization of p75(NTR) levels in HD mutant mice heterozygous for p75(NTR) prevented memory and synaptic plasticity deficits and ameliorated dendritic spine abnormalities, likely through normalization of the activity of the GTPase RhoA. Moreover, viral-mediated overexpression of p75(NTR) in the hippocampus of WT mice reproduced HD learning and memory deficits, while knockdown of p75(NTR) in the hippocampus of HD mice prevented cognitive decline. Together, these findings provide evidence of hippocampus-associated memory deficits in HD and demonstrate that p75(NTR) mediates synaptic, learning, and memory dysfunction in HD.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25180603      PMCID: PMC4191006          DOI: 10.1172/JCI74809

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  103 in total

Review 1.  The function of p75NTR in glia.

Authors:  Andrea B Cragnolini; Wilma J Friedman
Journal:  Trends Neurosci       Date:  2008-01-15       Impact factor: 13.837

Review 2.  Postsynaptic BDNF-TrkB signaling in synapse maturation, plasticity, and disease.

Authors:  Akira Yoshii; Martha Constantine-Paton
Journal:  Dev Neurobiol       Date:  2010-04       Impact factor: 3.964

Review 3.  Cognitive Dysfunction in Huntington's Disease: Humans, Mouse Models and Molecular Mechanisms.

Authors:  Albert Giralt; Ana Saavedra; Jordi Alberch; Esther Pérez-Navarro
Journal:  J Huntingtons Dis       Date:  2012

4.  Long-term memory deficits in Huntington's disease are associated with reduced CBP histone acetylase activity.

Authors:  A Giralt; M Puigdellívol; O Carretón; P Paoletti; J Valero; A Parra-Damas; C A Saura; J Alberch; S Ginés
Journal:  Hum Mol Genet       Date:  2011-11-24       Impact factor: 6.150

Review 5.  Experimental models of HD and reflection on therapeutic strategies.

Authors:  Jinho Kim; Olivia L Bordiuk; Robert J Ferrante
Journal:  Int Rev Neurobiol       Date:  2011       Impact factor: 3.230

6.  Emotion recognition and experience in Huntington disease: a voxel-based morphometry study.

Authors:  Rottraut Ille; Axel Schäfer; Wilfried Scharmüller; Christian Enzinger; Helmuth Schöggl; Hans-Peter Kapfhammer; Anne Schienle
Journal:  J Psychiatry Neurosci       Date:  2011-11       Impact factor: 6.186

7.  Stably maintained dendritic spines are associated with lifelong memories.

Authors:  Guang Yang; Feng Pan; Wen-Biao Gan
Journal:  Nature       Date:  2009-11-29       Impact factor: 49.962

Review 8.  Calcium/calmodulin-dependent protein kinase II and synaptic plasticity.

Authors:  Roger J Colbran; Abigail M Brown
Journal:  Curr Opin Neurobiol       Date:  2004-06       Impact factor: 6.627

9.  MDMA pretreatment leads to mild chronic unpredictable stress-induced impairments in spatial learning.

Authors:  Jacobi I Cunningham; Jamie Raudensky; John Tonkiss; Bryan K Yamamoto
Journal:  Behav Neurosci       Date:  2009-10       Impact factor: 1.912

10.  Executive functions in premanifest Huntington's disease.

Authors:  S Christine You; Michael D Geschwind; Sharon J Sha; Alexandra Apple; Gabriella Satris; Kristie A Wood; Erica T Johnson; Jonathan Gooblar; Jeanne S Feuerstein; Steven Finkbeiner; Gail A Kang; Bruce L Miller; Christopher P Hess; Joel H Kramer; Katherine L Possin
Journal:  Mov Disord       Date:  2013-12-27       Impact factor: 10.338

View more
  39 in total

1.  Changes in Dopamine Signalling Do Not Underlie Aberrant Hippocampal Plasticity in a Mouse Model of Huntington's Disease.

Authors:  Glenn M Dallérac; Damian M Cummings; Mark C Hirst; Austen J Milnerwood; Kerry P S J Murphy
Journal:  Neuromolecular Med       Date:  2016-01-18       Impact factor: 3.843

2.  Early Downregulation of p75NTR by Genetic and Pharmacological Approaches Delays the Onset of Motor Deficits and Striatal Dysfunction in Huntington's Disease Mice.

Authors:  Nuria Suelves; Andrés Miguez; Saray López-Benito; Gerardo García-Díaz Barriga; Albert Giralt; Elena Alvarez-Periel; Juan Carlos Arévalo; Jordi Alberch; Silvia Ginés; Verónica Brito
Journal:  Mol Neurobiol       Date:  2018-05-27       Impact factor: 5.590

3.  Pituitary Adenylate Cyclase-Activating Polypeptide (PACAP) Enhances Hippocampal Synaptic Plasticity and Improves Memory Performance in Huntington's Disease.

Authors:  N Cabezas-Llobet; L Vidal-Sancho; M Masana; A Fournier; J Alberch; D Vaudry; X Xifró
Journal:  Mol Neurobiol       Date:  2018-03-10       Impact factor: 5.590

4.  Cdk5 Contributes to Huntington's Disease Learning and Memory Deficits via Modulation of Brain Region-Specific Substrates.

Authors:  Elena Alvarez-Periel; Mar Puigdellívol; Verónica Brito; Florian Plattner; James A Bibb; Jordi Alberch; Silvia Ginés
Journal:  Mol Neurobiol       Date:  2017-12-29       Impact factor: 5.590

5.  Peripheral huntingtin silencing does not ameliorate central signs of disease in the B6.HttQ111/+ mouse model of Huntington's disease.

Authors:  Sydney R Coffey; Robert M Bragg; Shawn Minnig; Seth A Ament; Jeffrey P Cantle; Anne Glickenhaus; Daniel Shelnut; José M Carrillo; Dominic D Shuttleworth; Julie-Anne Rodier; Kimihiro Noguchi; C Frank Bennett; Nathan D Price; Holly B Kordasiewicz; Jeffrey B Carroll
Journal:  PLoS One       Date:  2017-04-28       Impact factor: 3.240

6.  Altered m6A RNA methylation contributes to hippocampal memory deficits in Huntington's disease mice.

Authors:  Silvia Ginés; Verónica Brito; Anika Pupak; Ankita Singh; Anna Sancho-Balsells; Rafael Alcalá-Vida; Marc Espina; Albert Giralt; Eulàlia Martí; Ulf Andersson Vang Ørom
Journal:  Cell Mol Life Sci       Date:  2022-07-11       Impact factor: 9.207

7.  The p75 neurotrophin receptor augments survival signaling in the striatum of pre-symptomatic Q175(WT/HD) mice.

Authors:  A B Wehner; A M Milen; R L Albin; B A Pierchala
Journal:  Neuroscience       Date:  2016-03-03       Impact factor: 3.590

8.  FGF2 and dual agonist of NCAM and FGF receptor 1, Enreptin, rescue neurite outgrowth loss in hippocampal neurons expressing mutated huntingtin proteins.

Authors:  Mirolyuba Ilieva; Troels T Nielsen; Tanja Michel; Stanislava Pankratova
Journal:  J Neural Transm (Vienna)       Date:  2019-09-09       Impact factor: 3.575

9.  Mutant Huntingtin Causes a Selective Decrease in the Expression of Synaptic Vesicle Protein 2C.

Authors:  Chaohua Peng; Gaochun Zhu; Xiangqian Liu; He Li
Journal:  Neurosci Bull       Date:  2018-04-30       Impact factor: 5.203

10.  A role for Kalirin-7 in corticostriatal synaptic dysfunction in Huntington's disease.

Authors:  Mar Puigdellívol; Marta Cherubini; Verónica Brito; Albert Giralt; Núria Suelves; Jesús Ballesteros; Alfonsa Zamora-Moratalla; Eduardo D Martín; Betty A Eipper; Jordi Alberch; Silvia Ginés
Journal:  Hum Mol Genet       Date:  2015-10-12       Impact factor: 6.150

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.